More patienceI too am excited by the potential here. But we’re still gonna have to be patient. Rebranding along with commercial lettuce/micro greens and early cannabis results won’t be announced until late March as that’s now when the annual meeting is. And they have many more trials planned for 2018. Health Canada yay or nay for the exemption application won’t come at least until spring. And LPs will only watch from a distance before that issue is settled. In the meantime I believe things will remain pretty flat and possibly even dip a little more as this stock doesn’t have the same “cannabis fever” as a lot of other stocks in the sector because cannabis is only part of BOC’s new focus. Assuming exemption happens, and concerns around this tech and it’s impact on cannabis are alleviated, I think we should start to climb. This is a long game stock (which suits me as I have no interest in day trading).